课题基金 / 基金详情

Protein inhibitor of Raf-1 kinase

Protein inhibitor of Raf-1 kinase
Raf-1 激酶的蛋白抑制剂
批准号:
6861829
负责人:
KAM C YEUNG
金额:
$21.35万
依托单位国家:
美国
项目类别:
财政年份:
2001
资助国家:
美国
项目状态:
已结题
起止时间:
2001-08-01 至 2006-12-31

项目摘要

项目成果

KAM C YEUNG的其他基金

相似基金

相关文献

中文摘要
翻译
申请人描述:本提案的目的是研究新的
英文摘要
APPLICANT'S DESCRIPTION: The goal of this proposal is to study the newly identified inhibitor of the Raf-l kinase designated RKJP. Raf-l is a cytoplasmic serine/threonine kinase whose activity plays a pivotal role in the control of the mitogen-activated protein kinase pathway (MAPK). Raf-1 kinase activity is tightly regulated by an interplay of positive and negative regulators. RKIP is a negative regulator of Raf-l and MAPK pathway signaling that was recently identified in a collaborative effort between my lab and the labs of Walter Kolch and David Rose. In this proposal I outline experiments to investigate two aspects of RKJP function. In Aim One I will investigate in detail the mechanism by which RKJP contributes to the regulation of the MAPK pathway. Specifically, I will investigate the role of phosphorylation in the regulation of the Raf-RKTP interaction. Several lines of evidence indicate that RKJP binds to phosphorylated residues on proteins. I will thus investigate whether the phosphorylation status of Raf- 1 plays a role in regulating the RKIP-Raf- 1 interaction. The second set of experiments is based on the observation that RKIP is a phosphoprotein in vivo and a substrate of several kinases in vitro. Sites of in vitro phosphorylation will be mapped. In vivo phosphorylation sites will be determined using a combination of mass spectrometry and metabolic labeling followed by peptide mapping and sequencing. Once in vivo sites are ascertained, phosphopeptide-specific antibodies will be raised. The in vivo phosphorylation status of RKIP will be examined under a variety of physiological conditions known to stimulate MAPK activity. In Aim Two I will investigate the role of RKIP in the NF-KB signaling cascade. I have obtained experimental evidence that modulation of RKIP expression levels affects NF-kB activation, and I have shown that RKIP physically interacts with two components of the NF-kB cascade, NIK and TAK 1. I will employ a combination of genetic and biochemical methods to study the effects of RKIP on NF-kB signaling. The primary goal of this line of investigation will be to define the targets of RKIP in the NF-kB signaling pathway, and to initiate studies into how they are regulated. In summary, I believe that the experiments in this proposal will provide a new handle for understanding Raf- 1 signaling, and will initiate studies to expose the full spectrum of RKIP functions.
期刊论文(6)
专著(0)
科研奖励(0)
会议论文
DOI: 10.1016/j.febslet.2009.12.051
发表时间: 2010-02-19
期刊: FEBS letters
影响因子: 3.5
作者: [Tang H, Park S, Sun SC, Trumbly R, Ren G, Tsung E, Yeung KC]
通讯作者: Yeung KC
RKIP regulation as a potential for tumor suppression
RKIP regulation as a potential for tumor suppression
Protein inhibitor of Raf-1 kinase
  • 批准号:
    6328408
  • 项目类别:
  • 资助金额:
    $5.07万
  • 财政年份:
    2001
  • 负责人:
    KAM C YEUNG
  • 依托单位:
Protein inhibitor of Raf-1 kinase
海外基金